BusinessAstraZeneca Halts Phase III Volrustomig Lung Cancer Trial After Efficacy SetbackBy Riza DagocAug 17, 2026, 8:44 AM UTC
BusinessModerna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+By Riza DagocAug 6, 2026, 4:41 AM UTC
BusinessNovo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema SetbackBy Riza DagocAug 5, 2026, 8:59 AM UTC
HealthNew Mexico Measles Outbreak Cost Reached $5.4 Million, Study FindsBy Riza DagocAug 4, 2026, 3:23 AM UTC
BusinessNovo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug RaceBy Riza DagocAug 3, 2026, 6:02 AM UTC
BusinessAstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 BillionBy Riza DagocAug 3, 2026, 12:55 AM UTC
